Vulvar and Vaginal Atrophy Treatment with Vaginally Administer Estrogen

A generic vaginal estrogen tablet for postmenopausal women who experience moderate to severe vulvar vaginal atrophy (VVA).

Eligible participants are: postmenopausal women age 30 to 75, experiencing moderate to severe vaginal dryness, painful intercourse, and vaginal irritation/itching, in good general health. Women who are new to menopausal hormone replacement therapy or willing to discontinue current hormonal treatments during screening and the treatment period are eligible. Length of study 1 month.

Medical insurance is not required for study participation and compensation for time and travel is provided. To learn more about the study or if you’re interested in enrolling, please contact Alisha Lutat, Vanessa Lukas, or Carol Mack, PA-C at 202-293-1000.